A Phase II Trial of Camrelizumab Combined With Famitinib for Adjuvant Treatment of Stage II-IIIA NSCLC.
Clinical trial NCT05005468 · UNKNOWN
Trial details
- NCT number
- NCT05005468
- Sponsor
- Shanghai Chest Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2023-08-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.